Mehul Patel | Qualified Person, Senior GMP Compliance Consultant
Commissioning Agents Inc | Singapore

Mehul Patel, Qualified Person, Senior GMP Compliance Consultant, Commissioning Agents Inc

Mehul is a Qualified Person registered in the UK under the permanent provision of 2001 83 EC. Mehul is a Principal GMP Consultant and CAI-India Business Senior Manager for the Commissioning Agents Inc[CAI]. Mehul has managed new pharmaceutical site Commissioning and Qualification projects for the CAI in Asian region(China, Vietnam,Singapore). Mehul has worked as a Senior Quality (Senior QA Manager & Director level)professional for many well known Biopharma and pharmaceutical companies such as Pfizer, GSK, Sanofi Genzyme, Merck and NHS where he has gained significant experience of automation and electronic data compliance management. During his career life, Mehul has gained hands on experience of Sterility assurance, Biopharm and cell/gene therapy products manufacturing process, Quality Control, EU Regulatory framework, GMP audits (Biopharm, API and Finished products), Data integrity assessments , Quality Risk Management, Remediation of critical failures and regulatory findings, Verification and validation of analytical methods, and Validation of process in the Biotechnological, Pharmaceutical industries.

Mehul has acted as a guest lecturer at the University College London, where he has developed training presentations for GMP, GDP, Good data management, Regulatory inspection management, rapid microbial methods and good aseptic behavior. Mehul has carried out training session on automated Cold Chain Management of blood products at the Regents college London & Guys and St Thomas hospital. 

Appearances:



Conference Day 1 @ 14:00

Automation to reduce human error in India’s biologics manufacturing

  •     Identifying prevalent human errors in manufacturing processes
  •     Exploring possible automation solutions to eradicate
  •     Analysis on productivity improvements
  •     How does increased automation improve GMP compliance of the future of Biopharmaceuticals and how to achieve EU GMP compliance 

back to speakers